.no-js-message{position:fixed;top:0;left:0;right:0;background:#222;color:#fff;padding:8px 12px;font-size:14px;z-index:10000;text-align:center}JavaScript is disabled. The site works, but some features may be limited.

INDIA
MONEY
TRAVELLER
EATS
RESPAWN
LUXE

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Delivery within India

Delivery outside India

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Budget 2026
Magazine
Markets
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
Newsletters
News
AI
Videos
Start-Up
Planet

Budget 2026
Magazine
Markets
OB Datalens
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
Newsletters
News
AI
Videos
Start-Up
Planet
Tech
Spotlight
Magazine Special Edition
Initiatives
- Spotlight
- C3
About Us

Budget 2026
Magazine
Markets
Corporate
Economy & Policy
Newsletters
News
AI
Videos
Start-Up
Planet

home
Topic
Biocon

Biocon

John Shaw, Husband Of Biocon Chief Kiran Mazumdar Shaw, Passes Away At 73

John Shaw, Husband Of Biocon Chief Kiran Mazumdar Shaw, Passes Away At 73

BY Press Trust of India

Biocon Sells 5.4% Stake In Arm Syngene International

Biocon Sells 5.4% Stake In Arm Syngene International

BY Press Trust of India

Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval

Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval

BY Press Trust of India

Source: Shutterstock

CBI Arrests Joint Drug Controller For Alleged Bribery To Favour Biocon Biologics' Medicine

BY Press Trust of India

Biocon Q4 Profit Declines By 4% To Rs 283 Crore

Biocon Q4 Profit Declines By 4% To Rs 283 Crore

BY Press Trust of India

Following this development Biocon shares fell as much as 8 per cent to hit an intraday low of Rs 362

Biocon To Acquire Viatris' Biosimilar Assets For Up To $3.335 Billion

BY Outlook Business Desk

Biocon To Launch Drug For COVID-19 Patients

Biocon To Launch Drug For COVID-19 Patients

BY PTI

Advertisement

Betting big on biosimilars

Betting big on biosimilars

BY Himali Patel

Close Ad

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2026 Outlook Publishing India Pvt Ltd.

Copyright © 2026 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.